EIF2AK3 and central nervous system cancer: Our study for the first time demonstrated that PERK was clearly activated in human glioma tissues compared with nontumor brain tissues, more importantly, PERK silencing in glioma cells inhibited tumor growth in vivo, which suggested that PERK activation may play an important role for human glioma development.